Literature DB >> 11205374

Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells.

K Steinbrink1, F Schönlau, U Rescher, U Henseleit, T Vogel, C Sorg, C Sunderkötter.   

Abstract

Myeloid-related protein (MRP) 14, an intracellular protein involved in calcium-dependent activation of myeloid cells, presents a differentiation marker for a subtype of macrophages. In experimental leishmaniasis, BALB/c mice succumb to visceral dissemination after infection with L. major, due to a Th2 cell response, while C57Bl/6 mice develop protective immunity associated with a Th1 cell response. We have previously shown that resistance in (C57Bl/6 mice was also associated with a significantly lower percentage of MRP14-positive cells in the infiltrate than in susceptible BALB/c mice. In C57Bl/6 mice, weekly injections of bone marrow (BM) cells enriched with MRP14-positive cells (d1 of culture) did not reverse, but prolonged the course of infection, associated with increased local parasite spread. In BALB/c mice a single dose of an antiphlogistic agent (dexamethasone or lipoxygenase inhibitor) was associated with reduction of infiltrating MRP14-positive cells and also with a decrease of parasite loads in footpads, lymph nodes as well as spleens, and with delayed progression of disease, Double labeling experiments in vitro revealed that at least 43.1% of MRP14-positive mononuclear cells in BM cultures (8h) had phagocytosed parasites after 4 h of co-incubation. Activation by IFN-gamma (20 U/ml) for 24h and 48h did not significantly reduce parasite load in these cells. In contrast, 77.0% of F4/80-positive macrophages (6d of culture) were infected with L. major parasites and these cells responded to activation with IFN-gamma (20 U/ml) with significant reduction of parasite load (25.3%). The protein MRP14 did not have an effect on parasite survival in vitro. Thus, the impaired capability of MRP14-positive cells to kill L. major upon stimulation may be one reason for the adverse course of infection observed with their increased appearance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205374     DOI: 10.1016/s0171-2985(00)80103-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

1.  Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Authors:  Steve Oghumu; James C Stock; Sanjay Varikuti; Ran Dong; Cesar Terrazas; Jessica A Edwards; Chad A Rappleye; Ariel Holovatyk; Arlene Sharpe; Abhay R Satoskar
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

2.  High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.

Authors:  Cord H Sunderkötter; Jane Tomimori-Yamashita; Verena Nix; Solange M Maeda; Anca Sindrilaru; Mario Mariano; Clemens Sorg; Johannes Roth
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

3.  Proteomic and systems biology analysis of the monocyte response to Coxiella burnetii infection.

Authors:  Matt Shipman; Kirk Lubick; David Fouchard; Rajani Gurram; Paul Grieco; Mark Jutila; Edward A Dratz
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

4.  Innate immunity to Leishmania infection: within phagocytes.

Authors:  Marcela Freitas Lopes; Ana Caroline Costa-da-Silva; George Alexandre DosReis
Journal:  Mediators Inflamm       Date:  2014-07-07       Impact factor: 4.711

5.  All-Trans Retinoic Acid Promotes an M1- to M2-Phenotype Shift and Inhibits Macrophage-Mediated Immunity to Leishmania major.

Authors:  Natália S Vellozo; Sâmara T Pereira-Marques; Mariela P Cabral-Piccin; Alessandra A Filardy; Flávia L Ribeiro-Gomes; Thaís S Rigoni; George A DosReis; Marcela F Lopes
Journal:  Front Immunol       Date:  2017-11-17       Impact factor: 7.561

6.  RANK Ligand Helps Immunity to Leishmania major by Skewing M2-Like Into M1 Macrophages.

Authors:  Thaís S Rigoni; Natália S Vellozo; Mariela Cabral-Piccin; Laryssa Fabiano-Coelho; Ulisses G Lopes; Alessandra A Filardy; George A DosReis; Marcela F Lopes
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

Review 7.  New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.

Authors:  Natália S Vellozo; Thaís S Rigoni; Marcela F Lopes
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

8.  2,3,7,8-tetrachlorodibenzo-p-dioxin slows the progression of experimental cutaneous Leishmaniasis in susceptible BALB/c and SCID mice.

Authors:  Gregory K DeKrey; Riane E Teagarden; Jerica L Lenberg; Richard G Titus
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

9.  Salivary Gland Extract Modulates the Infection of Two Leishmania enriettii Strains by Interfering With Macrophage Differentiation in the Model of Cavia porcellus.

Authors:  Lucélia J Pinheiro; Larissa F Paranaíba; Adriano F Alves; Patrícia M Parreiras; Nelder F Gontijo; Rodrigo P Soares; Wagner L Tafuri
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

10.  Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.

Authors:  Kanna Ishizuka; Wataru Fujii; Natsuho Azuma; Haruka Mizobuchi; Ayako Morimoto; Chizu Sanjoba; Yoshitsugu Matsumoto; Yasuyuki Goto
Journal:  PLoS Negl Trop Dis       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.